Medicare can cover Eli Lilly’s Zepbound for sleep apnea: Health Department agency

admin January 10, 2025 0 Comments

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Medicare drug plans can now cover Eli Lilly‘s blockbuster obesity drug Zepbound for obstructive sleep apnea, CNBC confirmed on Wednesday.  That opens the door for broader access to Zepbound, which is […]

Read MoreRead More

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea

admin December 21, 2024 0 Comments

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024.  Shelby Knowles | Bloomberg | Getty Images The Food and Drug Administration on Friday approved Eli Lilly‘s blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder, expanding […]

Read MoreRead More